AffiliationTranscriptional Networks in Lung Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Wilmslow Road, Manchester, M20 4BX
MetadataShow full item record
AbstractDrug resistance is a major problem in the treatment of cancer patients. Resistance can develop after prolonged cycles of chemotherapy or can be present intrinsically in the patient. There is an emerging role of microRNAs (miRNAs) in resistance to cancer treatments. miRNAs are small non-coding RNAs that are evolutionarily conserved and also involved as regulators of gene expression through the silencing of mRNA targets. They are involved in many different cancer types and a plethora of mechanisms have been postulated for the roles that miRNAs play in the development of drug resistance. Hence, miRNA-based gene therapy may provide a novel approach for the future of cancer therapy. This review focuses on an overview of recent findings on the role of miRNAs in the resistance to chemotherapy in different tumours.
CitationRole of microRNAs in chemoresistance. 2015, 3 (21):332 Ann Transl Med
JournalAnnals of Translational Medicine
- MicroRNA and drug resistance.
- Authors: Ma J, Dong C, Ji C
- Issue date: 2010 Aug
- The emerging role of microRNAs in resistance to lung cancer treatments.
- Authors: MacDonagh L, Gray SG, Finn SP, Cuffe S, O'Byrne KJ, Barr MP
- Issue date: 2015 Feb
- microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance.
- Authors: Naidu S, Garofalo M
- Issue date: 2015
- Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.
- Authors: Ayers D, Vandesompele J
- Issue date: 2017 Mar 3
- MicroRNAs: short non-coding players in cancer chemoresistance.
- Authors: Donzelli S, Mori F, Biagioni F, Bellissimo T, Pulito C, Muti P, Strano S, Blandino G
- Issue date: 2014